Cutler Group LP Seagen Inc. Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$191.51 - $216.16 $938,399 - $1.06 Million	4,900 New	4,900 $1.04 Million
Q1 2023 May 01, 2023	BUY	$127.59 - $203.08 $63,795 - $101,540	500 New	500 $101,000
Q3 2022 Oct 25, 2022	BUY	$135.27 - $180.11 $69,664 - $92,756	515 Added 32.57%	2,096 $286,000
Q2 2022 Aug 04, 2022	SELL	$108.81 - $179.33 $189,002 - $311,496	-1,737 Reduced 52.35%	1,581 $279,000
Q1 2022 Apr 14, 2022	BUY	$119.61 - $157.85 $325,099 - $429,036	2,718 Added 453.0%	3,318 $477,000
Q3 2021 Oct 26, 2021	SELL	$142.45 - $169.82 $7,122 - $8,491	-50 Reduced 7.69%	600 $101,000
Q4 2020 Jan 21, 2021	BUY	$164.63 - $211.93 $107,009 - $137,754	650 New	650 $113,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.